Recently, there has been an exploration of the potential therapeutic approach to alleviate lipopolysaccharides (LPS) or E. coli-induced endometritis by activating the NRF2 signaling pathway or inhibiting the TLR4/NF-κB and MAPK signaling pathways transduction in mice [6,7,8]. Here, NFKB1 is linked to endometritis.